Skip to content
StockMarketAgent
Direct answer
Coca-Cola Europacific Partners (CCEP) is an entrenched, high-quality bottler generating roughly $2 billion in annual free cash flow. While it operates with structurally lower margins than franchisors like KO, its local monopoly on distribution and vast scale provide a wide economic moat. It is a predictable compounder actively returning capital through dividends and buybacks. Fair value range: low $91.3, high $140, with mid-point at $116.
Stock analysis

CCEP fair value $91–$140

By StockMarketAgent.AI team· supervised by
Analiz edildi: 2026-05-20Sonraki güncelleme: 2026-08-20Methodology v2.4Data cut-off: Quality gate: passSources: all material sources passed deterministic freshness/provenance gatesReview: automatedArchetype: Mature compounder
View archive
Fiyat
$91.86
▲ +23.88 (+26.00%)
Gerçeğe uygun değer
$116
$91–$140
Tavsiye
Güçlü Al
confidence 88/100
Yükseliş potansiyeli
+26.0%
upside to fair value
Güvenlik Marjı
$98.38
MoS level · 15%
Piyasa Değeri
$40.7B
P/E fwd 16.2
İngilizce yedekTR
Çeviri yapılırken İngilizce kaynak gösteriliyor
Bu rapor henüz çevrilmedi. Çeviri kuyruğu yetiştiğinde birkaç dakika sonra sayfayı yenileyin.

§1 Yönetici özeti

  • Defensive consumer staples compounder producing $2B+ in annual free cash flow.
  • Trading at a steep discount to structural moat-fade intrinsic value of $115.74.
  • Market implicitly prices zero-to-negative volume growth, ignoring durable ROIC.
  • Stable 13.3% operating margins prove successful pass-through of severe cost inflation.
Fair value
$116
Margin of safety
+20.6%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$91.86Price
Low $91.30
Mid $115.74
High $140.15

Coca-Cola Europacific Partners (CCEP) is an entrenched, high-quality bottler generating roughly $2 billion in annual free cash flow. While it operates with structurally lower margins than franchisors like KO, its local monopoly on distribution and vast scale provide a wide economic moat. It is a predictable compounder actively returning capital through dividends and buybacks.

  • Exclusive territorial distribution agreements for
    Exclusive territorial distribution agreements for top global beverage brands.
  • Massive local distribution density creating
    Massive local distribution density creating insurmountable scale advantages.
  • Cycle upside
    Normalized supply chains and highly stable consumer staples demand driving margin expansion.

§2 Olumsuz senaryo

Consumer elasticity reaches a tipping point amid sticky wage and packaging inflation, compressing operating margins back toward 10% and stunting free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics. generation.

Bu tezin bozulabileceği yollar

Elasticity Breakpoint

· Medium

Consumers reject sustained price hikes, driving permanent volume declines and private label substitution.

FV impact
Downside to $91.30
Trigger
12-24 Months

Franchisor Margin Extraction

· Low

Primary franchisor aggressively hikes concentrate pricing, forcing the bottler to absorb the margin compression.

FV impact
Sub-$80s Valuation
Trigger
24-36 Months

Capital Intensity Spike

· Low

Maintenance capex-to-D&A structurally rises above 1.2x, permanently impairing free cash flow conversion.

FV impact
15% Intrinsic Value Reduction
Trigger
36+ Months
İzlenecek erken uyarı sinyalleri
MetrikMevcutTetikleme eşiği
Operating margins compress below 12.0% for two consecutive quarters.MonitorDeterioration versus the report thesis
Maintenance capex-to-D&A structurally rises above 1.2x.MonitorDeterioration versus the report thesis
Volume declines exceed low-single digits despite flat macro environment.MonitorDeterioration versus the report thesis
Adverse shifts or renegotiations in franchisor territorial agreements.MonitorDeterioration versus the report thesis
Free cash flow conversion drops permanently below historical $2B baseline.MonitorDeterioration versus the report thesis

§3 Mali geçmiş

Gelir tablosu — son altı dönem
KalemT−0T−1T−2T−3CAGR
Dönem2022-12-312023-12-312024-12-312025-12-31Trend
Gelir$17.32B$18.30B$20.44B$20.90B+6.5%
Brüt kâr$6.22B$6.72B$7.21B$7.44B+6.1%
Faaliyet kârı$2.23B$2.33B$2.54B$2.79B+7.7%
Net kâr$1.51B$1.67B$1.42B$1.94B+8.8%
EPS (sulandırılmış)$3.29$3.63$3.08$4.26+9.0%
EBITDA$2.94B$3.16B$3.11B$3.77B+8.7%
R&D
SG&A$1.99B$2.20B$2.35B$2.35B+5.8%

Kalite puanları

Piotroski F-skor
7 / 9
0–9 kalite bileşkesi
Altman Z-skor
2.5
İflas riski (>3 güvenli)
Beneish M-skor
-2.61
Kazanç manipülasyonu riski
OCF / Net kâr
1.52×
>1 yüksek kazanç kalitesini gösterir
Muhasebe kalitesi kapısı
Pass
Sektöre göre ayarlanmış kapı
ROIC
12.1%
Yatırılan sermaye getirisi
Bölüm 3

Numbers analysis

Nakit akışı

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

Sermaye tahsisi

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Bireysel aboneler — §4 ve sonrası11 bölüm daha

Tam analizi okuyun — 11 bölüm daha.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Kapsanan her sembol için tam rapor
24 ay tavsiye arşivi
İzleme listesi brifingleri + tavsiye değişiklik uyarıları
Herhangi bir dilde PDF + DOCX dışa aktarma
Ücretsiz denemeyi başlat
İstediğin zaman iptal edebilirsin.
FAQ

CCEP — frequently asked questions

  1. Based on our latest analysis, CCEP looks meaningfully undervalued. The current price is $91.9 versus a composite fair-value midpoint of $116 (range $91.3–$140), which implies roughly 26.0% upside to the midpoint.
Related coverage

Names readers of CCEP also follow

Same archetype: mature-compounder